Actinic Keratosis Treatment Market Players, Demand, Revenue, Features, Application Size by Outlook to 2026

The global actinic keratosis treatment market size is expected to reach over USD 9.12 billion by 2026, according to a new study by Grand View Research Inc. It is anticipated to expand at a CAGR of 4.8% during the forecast period. The market is driven high prevalence of the disease, rapid technological advancements, and rise in consumer awareness.

Topical therapeutics generated the highest revenue among other therapeutic segments, in 2018. However, photodynamic therapy is anticipated to witness a healthy growth through the forecast period. Rising trend of photodynamic and combination therapies is expected to favorably drive the growth in near future.

North America led the actinic keratosis treatment market in 2018, driven by high prevalence of disease, presence of key manufacturers, and several awareness campigns initiated by public and provate organizations. North America is anticipated to maintain its leading position throughout the forecast period. Asia Pacific, on the other hand, is anticipated to witness the fastest growth, supported by a rising disposable income and favorable government initiatives.

Some key marekt players include Bausch Health Companies Inc.; LEO Pharma A/S; Almirall, S.A.; Biofrontera, Inc.; Nestlé S.A.; Sun Pharmaceutical Industries Ltd.; Novartis International AG; 3M Pharmaceuticals Inc.; Hill Dermaceuticals, Inc.; and Mylan N.V. They are developing novel kits and therapies or drugs to target population in the areas with high unmet clinical needs.

Browse full research report on Actinic Keratosis Treatment Market: https://www.grandviewresearch.com/industry-analysis/actinic-keratosis-ak-treatment-market

Further key findings from the study suggest:

• Topical therapeutics captured over 45% of the actinic keratosis treatment market share in 2018, driven by strong commercial sales of topical products
• Photodynamic therapy and photoenhancers are expected to witness the fastest growth over the forecast period
• Although hospitals led the end use in 2018, homecare is gaining ground swiftly
• Nearly 10% of all actinic keratosis cases advance into squamous cell cancer. The treatment of actinic keratosis as a cancer prevention strategy has fueled the treatment rates
• Strategic mergers and acquisitions among major players are one of the key growth drivers

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/actinic-keratosis-ak-treatment-market/request/rs1

Grand View Research has segmented the global actinic keratosis treatment market on the basis of therapy, drug class, end use, and region:

Actinic Keratosis Treatment Therapy Outlook (Revenue, USD Million, 2014 - 2026)

• Topical
• Surgery
• Photodynamic Therapy

Actinic Keratosis Treatment Drug Class Outlook (Revenue, USD Million, 2014 - 2026)

• Nucleoside Metabolic Inhibitors
• NSAIDs
• Immune Response Modifiers
• Photoenhancers
• Others

Actinic Keratosis Treatment End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Hospitals
• Private Clinics
• Homecare
• Others

Actinic Keratosis TreatmentRegional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Spain
• France
• Italy
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Hemodialysis Vascular Grafts Market Size Is Estimated To Reach $276.5 Million By 2025

The global hemodialysis vascular grafts market size is expected to reach USD 276.5 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.1% during the forecast period. Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.

The global hemodialysis vascular graft market, by raw material, was dominated by PTFE grafts with a revenue share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High product penetration, wide availability, and comparatively cheaper products are supplementing the dominance of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its adoption, owing to lower possibility of rejection and infection of these products.

North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of the market in the country can be attributed to growing number of renal impaired patients undergoing hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.

Developing economies such as China and India have lower availability of kidney donors as compared to developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing awareness regarding safety of AVG, and rising healthcare expenditure.

Browse full research report on Hemodialysis Vascular Grafts Market: https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market

Further Key Findings From the Report Suggest:

• North America dominated the market in 2017, owing to geightened awareness regarding treatment options available, increasing adoption of hemodialysis access grafts, and technological advancements in AVG
• Asia Pacific is anticipated to be the fastest growing regional hemodialysis vascular graft market with a CAGR of 6.6 % between 2018 and 2025
• Some of the key market players in this market are W.L. Gore & Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.; CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc. 

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market/request/rs1

Grand View Research has segmented the global hemodialysis vascular graft market on the basis of raw material types, and region:

Hemodialysis Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2014 - 2025)

• Polyester
• Polytetrafluoroethylene
• Polyurethane
• Biological Materials

Hemodialysis Vascular Grafts Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Fractional Flow Reserve Market: Global Latest Industry Trends, Trades, Supply, Demand, Prospects by 2026

The global fractional flow reserve market size is expected to reach USD 1.20 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 10.4% over the forecast period. widening base of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Furthermore, launch of novel devices in fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in May 2019, Philips launched IntraSight interventional applications platform. This platform offers comprehensive unit of IVUS, FFR, IFR and co-registration modalities to speed up the routine procedures and simplify complex interventions.

In an independent study by SCAI, in 2019 it was observed that FFR possess the capability to decide the treatment plan for Acute Coronary Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the physicians and provide effective treatment plan to patients, thereby increasing adoption of the same in coming five years.

Moreover, consolidation activities, such as acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, is likely to keep the market highly competitive and thereby, augur well for the overall market.

Browse full research report on Fractional Flow Reserve Market: https://www.grandviewresearch.com/industry-analysis/fractional-flow-reserve-ffr-market

Further key findings from the report suggest:

• FFR monitoring systems accounted for significant share of over 40.0% in 2018 owing to the extensive usage in single and multiple vessel CAD.
• FFR guidewires is expected grow at a profitable growth rate over the forecast period due to increase in fractional flow reserve procedures conducted globally.
• North America held the significant share of FFR devices industry as of 2018, due to the increased investment in R&D by the medical device companies. For instance, a bill was approved by the U.S. congress in May 2018 via which an individual can try unproven medical aids comprising drugs, medications and devices in case of severe illness.
• Asia Pacific regional FFR industry is anticipated to witness major growth due to rising healthcare spending and rise in diabetes cases in countries such as China and India.
• Some of the key companies operating in the fractional flow reserve market are OPSENS Medical, Abbott Laboratories, Boston Scientific, and Bracco S.p.A. among others.
• The industry participants are engaged in extensive research activities to develop novel FFR devices for diagnosis of cardiac disorders.

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/fractional-flow-reserve-ffr-market/request/rs1

Grand View Research has segmented the global fractional flow reserve report on the basis of product, application, and region:

Fractional Flow Reserve Product Outlook (Revenue, USD Million; 2014 - 2026)

• FFR guidewires
• FFR monitoring systems

Fractional Flow Reserve Application Outlook (Revenue, USD Million; 2014 - 2026)

• Multi-vessel coronary artery disease
• Single-vessel coronary artery disease

Fractional Flow Reserve Regional Outlook (Revenue, USD Million; 2014 - 2026)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K
• France
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• Turkey

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Cancer Immunotherapy Drug Discovery Outsourcing Market Players, Demand, Revenue, Features, Application, Opportunities, Share, Size by Outlook to 2025

The global cancer immunotherapy drug discovery outsourcing market size is projected to reach USD 1.7Billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 13.5% during the forecast period. Increasing prevalence of cancer and rising mortality associated with cancer, along with growing development in the field of cancer immunotherapy, are anticipated to stimulate the growth of the market.

In order to maintain pace with increasing competition in the cancer therapeutics industry, pharmaceutical companies spend 2.5% more than other high tech industries in the in-house R&D. Hence, they are swiftly shifting towards outsourcing of drug discovery in order to achieve lower in-house R&D costs.

Additionally, favorable tax credit allows pharmaceutical companies to appropriately plan their global projects with a reputed CRO and therefore, receive benefits and reduce problems associated with taxation authorities or other bodies administering such incentive programs.

Several new molecules for cancer immunotherapy and new immunotherapeutic options, such as tumor infiltrating lymphocytes, check point inhibitors immunomodulators, and CAR-T cell therapy, have been introduced. Some are in the pipeline and are being tested for their ability to provide better cancer treatment

Browse full research report on Cancer Immunotherapy Drug Discovery Outsourcing Market: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market

Further Key Findings From the Report Suggest:

• Monoclonal antibodies emerged as the largest segment in 2017 because of increasing regulatory approvals and higher efficacy
• Target identification and validation accounted for the largest share in the global market owing to higher costs incurred and increased investments in new drug development
• North America dominated the market with the largest share in 2017. Rising incidence of cancer and increasing demand for novel technologies are facilitating the dominance of the region during the forecast period
• Some of the key players are Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation; Celentyx Ltd.; ImmunXperts SA; Personalis, Inc.; STC Biologics; and Molecular Imaging, Inc. dominated the cancer immunotherapy drug discovery outsourcing market.

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market/request/rs1

Grand View Research has segmented the global cancer immunotherapy drug discovery outsourcing market based on drug type, service type, cancer type, and region:

Cancer Immunotherapy Drug Discovery Outsourcing Drug Type Outlook (Revenue, USD Million, 2014 - 2025)

• Monoclonal Antibodies
• Immunomodulators
• Oncolytic Viral Therapies and Cancer Vaccines

Cancer Immunotherapy Drug Discovery Outsourcing Service Type Outlook (Revenue, USD Million, 2014 - 2025)

• Target Identification and Validation
• Lead Screening and Characterization
• Cell Based Assays

Cancer Immunotherapy Drug Discovery Outsourcing Cancer Type Outlook (Revenue, USD Million, 2014 - 2025)

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Melanoma
• Prostate Cancer
• Head and Neck Cancer
• Ovarian Cancer
• Pancreatic Cancer

Cancer Immunotherapy Drug Discovery Outsourcing Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• India
• China
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Rabies Diagnostics Market Industry Research Report, Growth Trends and Competitive Analysis 2025

The global rabies diagnostics market size is expected to reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1% during the forecast period, according to a new report by Grand View Research, Inc. Development of various diagnostic assays ranging from detection of virus presence to final confirmation of infection helps launch effective disease control programs. This factor is anticipated to drive the market growth. These assays aid in defining epidemiologic patterns of the disease and thereby deliver appropriate information for designing the control and eradication programs. These programs have boosted the market growth by increasing the rate at which testing kits are adopted.

For example, in June 2018, the World Health Organization (WHO), the World Organization for Animal Health (OIE), the Global Alliance for Rabies Control (GARC), and the Food and Agriculture Organization of the United Nations (FAO) entered into a partnership for a plan, The United Against Rabies Collaboration. This plan aims for rabies prevention and management and empowering the under-served populations in afflicted countries.

Furthermore, the state and public health officials of the Department of Public Health and Human Services (DPHHS) along with the Department of Livestock of Montana, U.S., deal with awareness pertaining to the risk of virus exposure. They are engaged in training the population about various aspects of disease management including prevention, detection, and available treatment modes. Such initiatives are projected to create growth opportunities for the rabies diagnostics market during the forecast period.

Browse full research report on Rabies Diagnostics Market: https://www.grandviewresearch.com/industry-analysis/rabies-diagnostics-market

Further key findings from the report suggest:

• Fluorescent Antibody Test (FAT) held the largest market share in terms of revenue owing to the high usage and recommendation by the WHO. Great specificity, as compare to other conventional tests such as serology and histology tests bodes well for the adoption of these tests
• Amplification methods are expected to supplant a major portion of conventional methods, primarily due to several advantages associated with the usage
• Currently, major products deploy ELISA/immunohistochemistry techniques, resulting into a larger revenue share of this segment
• High prevalence of the disease in India and China coupled with growing government support has contributed to the dominance of Asia market over other regions
• Since, most of the countries in Europe are designated as rabies free jurisdictions, the Europe market is anticipated to grow at the slowest pace over the forecast period
• Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology Corporation; and Creative Diagnostics are some of the key entities in the rabies testing market. The companies engage in developing products for rabies eradication programs.

Browse request sample of this report by Grand View Research: 

https://www.grandviewresearch.com/industry-analysis/rabies-diagnostics-market/request/rs1

Grand View Research has segmented the global rabies diagnostics market on the basis of diagnostic method, technology, and region:

Rabies Diagnostics Diagnostic Method Outlook (Revenue, USD Million, 2014 - 2025)

• Fluorescent antibody test (FAT)
• Immunohistochemical test
• Amplification methods
• Histologic examination
• Serology tests

Rabies Diagnostics Technology Outlook (Revenue, USD Million, 2014 - 2025)

• ELISA/Immunohistochemistry
• Chromatography techniques
• PCR
• Others

Rabies Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Spain
• Asia Pacific
• India
• China
• Indonesia
• Latin America
• Brazil
• Middle East & Africa
• South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Infection Surveillance Solutions Market Size, Analytical Overview, Growth Factors, Demand And Trends Forecast To 2026

The global infection surveillance solutions market size is poised to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 14.3% during the forecast period. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in European Union (EU) from antibiotic resistant bacteria. The figure is expected to increase to 10 million deaths per year, if current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up AMR surveillance network in India.

Browse full research report on Infection Surveillance Solutions Market: https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market

Further key findings from the report suggest:

• Surgical site infections emerged as the most promising segment during the forecast period owing to increasing number of surgeries being performed worldwide
• On the basis of the product and services segment, the on-premise software segment commanded the largest share in the market owing to its increased usage
• North America dominated the market in 2017. Government programs and rising awareness about infection surveillance are facilitating the dominance of this region during the forecast period
• Asia Pacific is estimated to witness swift growth during the forecast period due to increasing establishment of hospital chains and huge patient population
• Few of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton; Dickinson and Company; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company).

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market/request/rs1

Grand View Research has segmented the global infection surveillance solutions market based on infection type, product and services, end use, and region:

Infection Surveillance Solutions Product and Services Outlook (Revenue, USD Million, 2014 - 2026)

• Software
• On-premise
• Web-based
• Services

Infection Surveillance Solutions Infection Type Outlook (Revenue, USD Million, 2014 - 2026)

• Surgical Site Infections (SSI)           
• Blood Stream Infections (BSI)
• Urinary Tract Infections (UTI)
• Others

Infection Surveillance Solutions End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Long Term Care Facilities     
• Hospitals
• Others (Clinics, and Ambulatory Surgical Centers)

Infection Surveillance Solutions Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa
• Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Hospital Gowns Market Key Industry Players, Size, Share, Future Trends, Revenue, Demand Analysis 2025

The global hospital gowns market size is expected to reach USD 3.87 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.3% during the forecast period. Increasing number of surgeries, several initiatives pertaining to hospital gowns taken by major players, and rising incidence of hospital-acquired infections (HAIs) are among the key factors projected to drive the market.

Rising number of surgeries globally is also poised to provide an upthrust to the market during the forecast period. For instance, as per Mölnlycke Health Care AB, 70 million surgical procedures are performed every year in Europe. The trend is creating a significant increase in the demand for hospital gowns as they are one of the essential requirements for surgical procedures. Furthermore, according to the Healthcare Cost and Utilization Project (HCUP), in 2014, around 9,942,000 surgeries were performed in U.S. ambulatory setting. Patient gowns provide protection against hospital-acquired infections to some extent owing to which surgeons recommend these gowns.

Key players are also taking initiatives to modify and redesign hospital gowns with an aim to improve the comfort level of patients. For instance, Medstar made a collaboration with New York health wear company, Care+Wear, where students of New York's Parsons School of Design have designed innovative patient gowns. These gowns have been put to test run in hospitals by the company in order to get quality assurance and based on that the product will be launched officially. Hence, such initiatives are likely to propel the market.

Browse full research report on Hospital Gowns Market: https://www.grandviewresearch.com/industry-analysis/hospital-gowns-market

Further key findings from the report suggest:

• In terms of revenue, surgical gowns are anticipated to register the highest CAGR during the forecast period. Rising number of surgeries worldwide and increasing cases of hospital-acquired infections are contributing to the growth of the segment
• By 2025, Asia Pacific is estimated to witness the fastest CAGR over the forecast period. Penetration of major players in untapped areas of this region is likely to stimulate the growth of the regional market
• Some of the key companies present in the market are Medline Industries, Inc.; Standard Textile Co., Inc.; Angelica Corporation; AmeriPride Services Inc.; and Cardinal Health.

Browse request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/hospital-gowns-market/request/rs1

Grand View Research has segmented the global hospital gowns market on the basis of type, risk type, usability, and region.

Hospital Gowns Type Outlook (Revenue USD Million, 2014 - 2025)

• Surgical Gowns
• Non-Surgical Gowns
• Patient Gowns

Hospital Gowns Risk Type Outlook (Revenue USD Million, 2014 - 2025)

• Minimal
• Low
• Moderate
• High

Hospital Gowns Usability Outlook (Revenue USD Million, 2014 - 2025)

• Disposable
• Low
• Average
• Premium
• Reusable
• Low
• Average
• Premium

Hospital Gowns Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia-Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com